New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
07:06 EDTOXFDOxford Immunotec appoints Louis O'Dea Chief Medical Officer
Oxford Immunotec announced that Louis O'Dea, MB, BCh, BAO, has joined the company as Chief Medical Officer. Dr. O'Dea served as the Chief Medical Officer and Head of Regulatory Affairs at Moderna Therapeutics.
News For OXFD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 11, 2014
08:56 EDTOXFDOxford Immunotec shares remain materially undervalued, says Cowen
Cowen said Oxford Immunotec shares remain materially undervalued following the company's technology day yesterday. The firm cited the company's pipeline and market opportunity along with solid management execution. Cowen reiterated its Outperform rating and $20 price target on Oxford Immunotec shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use